Balancing Efficacy With Toxicity Among the Agents for HCC - Hallo friendsTHE LEK NEWS, In the article you read this time with the title Balancing Efficacy With Toxicity Among the Agents for HCC, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Balancing Efficacy With Toxicity Among the Agents for HCC
link : Balancing Efficacy With Toxicity Among the Agents for HCC

Balancing Efficacy With Toxicity Among the Agents for HCC

Balancing Efficacy With Toxicity Among the Agents for HCC
Catherine Frenette, MD

Published Online:Nov 29, 2018

Catherine Frenette, MD: The 2 groups of lenvatinib [Lenvima] versus sorafenib [Nexavar] in the REFLECT trial were not stratified by AFP [alpha-fetoprotein] level. They were also not stratified by their underlying cause of liver disease. The patients in the lenvatinib group did have a slightly higher AFP than the patients in the sorafenib group. This may actually have resulted in a favorable imbalance in the positive for sorafenib. Additionally, hepatitis C patients were more frequent in the sorafenib group as compared with the lenvatinib group. This may have given a benefit to sorafenib. The reason for this discussion is that we recall, in the SHARP trial, when they broke out a subgroup of patients who were treated with sorafenib and had hepatitis C, had quite a longer median survival. In the SHARP trial, the overall survival [OS] in the subgroup was 10.7 months. In the hepatitis C–treated population with sorafenib, there may have been a longer OS than would have been seen in patients who were stratified for that risk factor.....

Transcript

Continue reading

https://www.targetedonc.com/case-based-peer-perspectives/hepatocellular-carcinoma/frenette-unresectable-hcc/balancing-efficacy-with-toxicity-among-the-agents-for-hcc

Thus Article Balancing Efficacy With Toxicity Among the Agents for HCC

That's an article Balancing Efficacy With Toxicity Among the Agents for HCC This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Balancing Efficacy With Toxicity Among the Agents for HCC with the link address https://theleknews.blogspot.com/2018/11/balancing-efficacy-with-toxicity-among.html

Tweet

Subscribe to receive free email updates: